|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...2627282930313233343536...110111» |
- MEDI0457 / AstraZeneca
Enrollment change, Trial withdrawal, Combination therapy, Metastases: A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer (clinicaltrials.gov) - May 13, 2016
P2, N=0, Withdrawn, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
N=126 --> 0 | Not yet recruiting --> Withdrawn
- Enrollment open: Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium (clinicaltrials.gov) - May 13, 2016
P1, N=10, Recruiting, Sponsor: University of California, San Diego
N=126 --> 0 | Not yet recruiting --> Withdrawn Not yet recruiting --> Recruiting
- Trial completion: Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project (clinicaltrials.gov) - May 13, 2016
P=N/A, N=239, Completed, Sponsor: University of Oslo
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment closed: Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients (clinicaltrials.gov) - May 13, 2016
P=N/A, N=120, Active, not recruiting, Sponsor: University of Michigan
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: WSW: Sexually Transmitted Infections Among African American Women Who Have Sex With Women (clinicaltrials.gov) - May 11, 2016
P=N/A, N=300, Completed, Sponsor: University of Mississippi Medical Center
Recruiting --> Active, not recruiting Suspended --> Completed
- sevoflurane / Generic mfg.
Trial withdrawal: ECA/R: Regional Anesthesia and Endometrial Cancer Recurrence (clinicaltrials.gov) - May 9, 2016
P3, N=0, Withdrawn, Sponsor: The Cleveland Clinic
Suspended --> Completed Terminated --> Withdrawn
- Trial completion: Clinical Utility of Rapid CT/NG Testing in the ED (clinicaltrials.gov) - May 9, 2016
P=N/A, N=300, Completed, Sponsor: Johns Hopkins University
Terminated --> Withdrawn Recruiting --> Completed
- escitalopram / Generic mfg.
Trial completion, HEOR: The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS (clinicaltrials.gov) - May 9, 2016
P4, N=42, Completed, Sponsor: Odense University Hospital
Recruiting --> Completed Recruiting --> Completed
- New trial, Metastases: Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer (clinicaltrials.gov) - May 9, 2016
P=N/A, N=10, Recruiting, Sponsor: Mayo Clinic
- New P1/2 trial, Preclinical: LLLT: Effect of Low Level Laser Therapy on Endometrial Cells: An In Vitro Study (clinicaltrials.gov) - May 6, 2016
P1/2, N=40, Active, not recruiting, Sponsor: Cairo University
- | Kombiglyze XR (saxagliptin/metformin XR) / AstraZeneca
Trial primary completion date, Monotherapy: BMS-AZPCOS: Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis (clinicaltrials.gov) - May 6, 2016
P3, N=36, Active, not recruiting, Sponsor: Woman's
Recruiting --> Completed Trial primary completion date: Apr 2016 --> Jul 2016
- nimodipine / Generic mfg.
Enrollment change, Trial termination: Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients (clinicaltrials.gov) - May 6, 2016
P2, N=12, Terminated, Sponsor: Mount Sinai Hospital, Canada
Trial primary completion date: Apr 2016 --> Jul 2016 N=90 --> 12 | Active, not recruiting --> Terminated; small number of patients got recruited
- Enrollment open: ULMOST: Ultrasonic Versus Monopolar Energy-based Surgical Device in Colpotomy (clinicaltrials.gov) - May 5, 2016
P3, N=40, Recruiting, Sponsor: Kangbuk Samsung Hospital
N=90 --> 12 | Active, not recruiting --> Terminated; small number of patients got recruited Not yet recruiting --> Recruiting
- || lifastuzumab vedotin (DNIB0600A) / Roche
Enrollment closed: Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer (clinicaltrials.gov) - May 5, 2016
P1, N=87, Active, not recruiting, Sponsor: Genentech, Inc.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- New trial: Artificial Reproductive Techniques (ART) and Progression of Endometriosis Symptoms (clinicaltrials.gov) - May 5, 2016
P=N/A, N=144, Recruiting, Sponsor: University of Aarhus
- || Menopur (menotropin) / Ferring
Enrollment closed, Trial primary completion date: An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos (clinicaltrials.gov) - May 5, 2016
P=N/A, N=692, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Aug 2016
- || Bravelle (urofollitropin) / Ferring
Enrollment closed, Enrollment change, Trial primary completion date: Study of the Cleavage of the Egg in Relation to the Stimulation Treatment (clinicaltrials.gov) - May 5, 2016
P=N/A, N=272, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Aug 2016 Recruiting --> Active, not recruiting | N=600 --> 272 | Trial primary completion date: Nov 2016 --> Aug 2016
- Enrollment closed: 14 Weeks Exercise Training on Lean Women With and Without PCOS (clinicaltrials.gov) - May 4, 2016
P=N/A, N=22, Active, not recruiting, Sponsor: University of Copenhagen
Recruiting --> Active, not recruiting | N=600 --> 272 | Trial primary completion date: Nov 2016 --> Aug 2016 Recruiting --> Active, not recruiting
- || New P3 trial: Clinical Pregnancy Rate After Removal of Unsuspected Polyps (clinicaltrials.gov) - May 4, 2016
P3, N=200, Not yet recruiting, Sponsor: Karachi Medical and Dental College
- Gralise (gabapentin) / Alvogen
Trial completion: A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response (clinicaltrials.gov) - May 4, 2016
P=N/A, N=230, Completed, Sponsor: University of Tennessee
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial primary completion date: A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors (clinicaltrials.gov) - May 3, 2016
P=N/A, N=60, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Active, not recruiting --> Completed Trial primary completion date: Jun 2016 --> Jun 2017
- Trial primary completion date: A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer (clinicaltrials.gov) - May 3, 2016
P=N/A, N=600, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Trial primary completion date: Jun 2016 --> Jun 2017 Trial primary completion date: Jul 2016 --> Jul 2017
- Lynparza (olaparib) / Merck (MSD), AstraZeneca
Enrollment change, Trial withdrawal, Monotherapy, BRCA Biomarker, PARP Biomarker: Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations (clinicaltrials.gov) - May 2, 2016
P3, N=0, Withdrawn, Sponsor: AstraZeneca
Trial primary completion date: Jul 2016 --> Jul 2017 N=167 --> 0 | Not yet recruiting --> Withdrawn
- cefixime / Generic mfg., azithromycin / Generic mfg.
Enrollment open: Cefixime / Azithromycin pK Study (clinicaltrials.gov) - May 2, 2016
P1, N=8, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=167 --> 0 | Not yet recruiting --> Withdrawn Not yet recruiting --> Recruiting
- Enrollment open, Trial primary completion date: Understanding the Value of Community Vital Signs in Primary Care (clinicaltrials.gov) - May 2, 2016
P=N/A, N=170000, Recruiting, Sponsor: Virginia Commonwealth University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2016 --> Aug 2016
- New trial: Quantitative MRI for Functional Imaging of the Testis: A New Methodology for Evaluation of the Infertile Male (clinicaltrials.gov) - May 2, 2016
P=N/A, N=20, Not yet recruiting, Sponsor: New York University School of Medicine
- New P4 trial: Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors (clinicaltrials.gov) - May 2, 2016
P4, N=35, Not yet recruiting, Sponsor: Institut Universitari Dexeus
- || veliparib (ABT-888) / AbbVie
Trial primary completion date, BRCA Biomarker: A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors (clinicaltrials.gov) - Apr 28, 2016
P1, N=60, Active, not recruiting, Sponsor: AbbVie
Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2016 --> Aug 2016 Trial primary completion date: Feb 2016 --> Nov 2016
- anastrozole / Generic mfg.
Trial completion: Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence (clinicaltrials.gov) - Apr 28, 2016
P4, N=70, Completed, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Trial primary completion date: Feb 2016 --> Nov 2016 Recruiting --> Completed
- Trial completion, Trial primary completion date: Use of GM-CSF Supplemented IVF Medium in Patients With Recurrent Implantation Failure (clinicaltrials.gov) - Apr 28, 2016
P4, N=100, Completed, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: May 2015 --> Dec 2015
- | Firmagon (degarelix) / Astellas, Ferring
Trial completion, Trial primary completion date: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) (clinicaltrials.gov) - Apr 28, 2016
P3, N=80, Completed, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Recruiting --> Completed | Trial primary completion date: May 2015 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2015
- danazol oral / Generic mfg.
Trial completion: Danazol Treatment in Endometriosis Women Before IVF (clinicaltrials.gov) - Apr 27, 2016
P4, N=150, Completed, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2015 Recruiting --> Completed
- || Trial primary completion date: Performance and Safety Trial of an Innovative Female Condom (Wondaleaf®) (clinicaltrials.gov) - Apr 27, 2016
P=N/A, N=126, Recruiting, Sponsor: Clinical Research Centre, Malaysia
Recruiting --> Completed Trial primary completion date: Feb 2016 --> Sep 2016
- Trial initiation date, Trial primary completion date: The Application of Probe-based Confocal Laser Endomicroscopy in the Diagnosis of Deep Endometriosis (clinicaltrials.gov) - Apr 27, 2016
P=N/A, N=10, Not yet recruiting, Sponsor: Dr. Ofir Harnoy MD
Trial primary completion date: Feb 2016 --> Sep 2016 Initiation date: Oct 2015 --> May 2016 | Trial primary completion date: Jun 2016 --> May 2017
- Impracor (ketoprofen) / Harrow Health
Trial completion, Enrollment change, Trial primary completion date: Novel Topical Therapies for the Treatment of Genital Pain (clinicaltrials.gov) - Apr 27, 2016
P2/3, N=9, Completed, Sponsor: University of Rochester
Initiation date: Oct 2015 --> May 2016 | Trial primary completion date: Jun 2016 --> May 2017 Enrolling by invitation --> Completed | N=30 --> 9 | Trial primary completion date: Dec 2015 --> Jun 2015
- Enrollment closed, Enrollment change: Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. (clinicaltrials.gov) - Apr 27, 2016
P=N/A, N=16, Active, not recruiting, Sponsor: Mauna Kea Technologies
Enrolling by invitation --> Completed | N=30 --> 9 | Trial primary completion date: Dec 2015 --> Jun 2015 Recruiting --> Active, not recruiting | N=75 --> 16
- Enrollment change, Trial primary completion date: Model Development and Prospective Validation to Predict the Response to Neoadjuvant Chemotherapy in Cervical Cancer (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=1400, Recruiting, Sponsor: Ding Ma
Recruiting --> Active, not recruiting | N=75 --> 16 N=400 --> 1400 | Trial primary completion date: Dec 2013 --> Dec 2018
- || Enrollment closed, BRCA Biomarker, IO biomarker: ENGAGE: Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=550, Active, not recruiting, Sponsor: AstraZeneca
N=400 --> 1400 | Trial primary completion date: Dec 2013 --> Dec 2018 Recruiting --> Active, not recruiting
- Trial primary completion date: Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=200, Enrolling by invitation, Sponsor: University of Alabama at Birmingham
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2017 --> Dec 2018
- Trial primary completion date: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) (clinicaltrials.gov) - Apr 26, 2016
P2, N=233, Completed, Sponsor: Harold Wiesenfeld
Trial primary completion date: Dec 2017 --> Dec 2018 Trial primary completion date: Mar 2015 --> Aug 2015
- zoliflodacin (ETX0914) / Entasis Therap, Global Antibiotic Research and Development Partnership
Trial completion: Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea (clinicaltrials.gov) - Apr 26, 2016
P2, N=180, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Mar 2015 --> Aug 2015 Active, not recruiting --> Completed
- || STM-434 / Atara
Trial primary completion date, Combination therapy, Metastases: Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors (clinicaltrials.gov) - Apr 25, 2016
P1, N=81, Recruiting, Sponsor: Santa Maria Biotherapeutics
Active, not recruiting --> Completed Trial primary completion date: Jul 2016 --> Jul 2017
- veliparib (ABT-888) / AbbVie
Trial primary completion date, Combination therapy: A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors (clinicaltrials.gov) - Apr 25, 2016
P1, N=48, Active, not recruiting, Sponsor: AbbVie
Trial primary completion date: Jul 2016 --> Jul 2017 Trial primary completion date: Jun 2016 --> Mar 2016
- sildenafil cream (SST-6006) / Daré Biosci, Strategic Science & Technologies
Trial primary completion date: Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder (clinicaltrials.gov) - Apr 25, 2016
P2a, N=30, Recruiting, Sponsor: Strategic Science & Technologies, LLC
Trial primary completion date: Jun 2016 --> Mar 2016 Trial primary completion date: Dec 2015 --> Sep 2016
- Clinical: Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis (clinicaltrials.gov) - Apr 25, 2016
P2, N=120, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Dec 2015 --> Sep 2016 Not yet recruiting --> Recruiting
- | Trial completion, Trial primary completion date: Impact on Ovarian Reserve of Diode Laser vs Bipolar Coagulation of Endometriomas (clinicaltrials.gov) - Apr 23, 2016
P=N/A, N=50, Completed, Sponsor: University of Cagliari
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Jan 2017 --> Aug 2015
- Biomarker, Trial primary completion date: Vitamin D Treatment, Pharmacogenetics and Glucose Metabolism (clinicaltrials.gov) - Apr 22, 2016
P4, N=300, Recruiting, Sponsor: Medical University of Graz
Recruiting --> Completed | Trial primary completion date: Jan 2017 --> Aug 2015 Trial primary completion date: Jul 2016 --> Dec 2016
- New trial: Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects (clinicaltrials.gov) - Apr 22, 2016
P0, N=15, Not yet recruiting, Sponsor: Alma Lasers Inc.
- New trial, HEOR: IMBSRADQWIUA: Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and QOL in Women With Intrauterine Adhesion. (clinicaltrials.gov) - Apr 21, 2016
P=N/A, N=226, Completed, Sponsor: Yuqing Chen
- dexamethasone / Generic mfg.
Trial primary completion date: dexFEM: Dexamethasone for Excessive Menstruation (clinicaltrials.gov) - Apr 21, 2016
P2, N=128, Recruiting, Sponsor: University of Edinburgh
Trial primary completion date: Jul 2016 --> Dec 2016 Trial primary completion date: Sep 2016 --> Sep 2017